A revolutionary vaccine to reduce cholesterol levels by 30% has been developed.

American scientists have developed this vaccine/file photo

Excess body fat or high cholesterol increases the risk of heart disease, including stroke and heart attack. But now progress has been made in developing a vaccine to prevent harmful LDL cholesterol.

A team of experts from the University of California, USA is developing this vaccine. This vaccine works to lower LDL cholesterol levels by targeting a protein called PCSK9.

What is the minimum amount of exercise necessary to prevent high blood pressure?

The vaccine was tested on monkeys and rats. During these experiments, the researchers succeeded in reducing LDL cholesterol levels in the animals.

According to the researchers, this vaccine is based on non-infectious viral particles. He further said that it is the shell of the virus and it proves that vaccines can be developed from the shell of a virus to prevent various diseases.

What are the health effects of staying up late at night? 

Research has shown that special receptors in liver cells keep LDL levels at a safe level, but excess PCSK9 in the body damages these receptors.

As a result, the functions of the receptors are not very effective, and the amount of cholesterol in the blood increases. Genes, diet, and many other factors influence the process of making this protein. Trials of the vaccine so far have shown that it can reduce LDL cholesterol levels by up to 30 percent.

Eating this food for breakfast is useful for reducing body weight according to the researchers, it can't be called completely effective yet, but it can still protect against several problems.

He said that we are trying to develop a vaccine that is cheap and can be used on a large scale. He said that it may take a long time before this vaccine is made available for general use, but the results so far have been encouraging.

Want to avoid diseases like high blood pressure?  

So make it a habit to use this common thing. The vaccine will now be tested on humans after which approval for its use will be subject to regulatory approval.

According to the researchers, we expect that within the next 10 years, a vaccine will be available to people to prevent cholesterol. The results of this study were published in NPJ Vaccines.